Search / Trial NCT06615713

Evaluate the Safety and Effectiveness of Steerable Ureteroscopic Renal Evacuation (SURE) Using the CVAC® System

Launched by CALYXO, INC. · Sep 24, 2024

Trial Information

Current as of October 03, 2024

Unknown status

Keywords

Description

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Candidate for ureteroscopy with laser lithotripsy;
  • * Be willing and able to return for and respond to all study-related follow up procedures; and,
  • * Have been informed of the nature of the study and have agreed to the IRB approved informed consent form (ICF).
  • Exclusion Criteria:
  • * Significant morbidities;
  • * Unable to meet the treatment and follow up protocol requirements; and,
  • * Ureteral or kidney abnormalities.

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Nadiad, , India

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0